𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy of Entecavir-Tenofovir Combination Therapy for Chronic Hepatitis B Patients with Multidrug-Resistant Strains

✍ Scribed by Lee, Y. B.; Lee, J.-H.; Lee, D. H.; Cho, H.; Ahn, H.; Choi, W.-M.; Cho, Y. Y.; Lee, M.; Yoo, J.-J.; Cho, Y.; Cho, E. J.; Yu, S. J.; Kim, Y. J.; Yoon, J.-H.; Kim, C. Y.; Lee, H.-S.


Book ID
126890904
Publisher
American Society for Microbiology
Year
2014
Tongue
English
Weight
930 KB
Volume
58
Category
Article
ISSN
0066-4804

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Adefovir-based combination therapy with
✍ Soon Sun Kim; Jae Youn Cheong; Dami Lee; Myoung Hee Lee; Sun Pyo Hong; Soo-Ok Ki πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 160 KB

This study evaluated the efficacy of adefovir (ADV) plus lamivudine (LAM) or ADV add-on therapy for patients with entecavir (ETV)-refractory hepatitis B infection. Twenty-nine ETVresistant and 8 patients with suboptimal response to ETV were enrolled. Twenty-seven patients received ADV ΓΎ LAM therapy

Antiviral efficacy of combination therap
✍ Hyo-Joon Yang; Jeong-Hoon Lee; Yoon Jun Kim; Jung-Hwan Yoon; Hyo-Suk Lee πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 172 KB

## Abstract There is little clinical information on the management of hepatitis B virus (HBV) that is resistant to multiple drugs including entecavir (ETV). The present retrospective cohort study assessed the antiviral efficacy of ETV/adefovir dipivoxil (ADV) combination therapy for ETV‐resistant H